Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 S16-p
CAMK2D T17-p
PKACA S16-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 S16-p
Phosphatases, in vitro:
PPP1CA S16-p , T17-p
Regulatory protein:
ADCY6 T17-p
ADCY6 S16-p , T17-p
Akt1 S16-p
Calmodulin T17-p
CAMK2A T17-p
CAMK2B T17-p
PMCA4 iso2 S16-p
PRKD1 S16-p
Treatment:
5-Methoxytryptophan S16-p , T17-p
8-Rp-cAMP S16-p
acidosis S16-p , T17-p
Akt-I-1 S16-p
Akt-I-1,2 S16-p
aortic banding S16-p , T17-p
autocamtide_inhibitory_peptide T17-p
azaserine S16-gl
Ba(2+) T17-p
Bay 60-7550 S16-p , T17-p
bradykinin S16-p , T17-p
Ca(2+) S16-p , T17-p
calyculin_A T17-p
cariporide S16-p
ciclosporin S16-p , T17-p
cigarette smoke extract S16-p , T17-p
colforsin S16-p , T17-p
CPA S16-p
electrical_stimulation S16-p , T17-p
empagliflozin S16-p
endothelin S16-p
exercise S16-p , T17-p
exercise training S16-p , T17-p
FK506 S16-p , T17-p
Go_6976 S16-p , T17-p
H-89 S16-p , T17-p
high_glucose S16-gl
hypertension S16-p , T17-p
ibrutinib S16-p , T17-p
ICI-118,551 S16-p
inhibitor-1 S16-p , T17-p
ionomycin T17-p
ischemia S16-p , T17-p
ischemia/reperfusion S16-p , T17-p
isoproterenol S16-p , T17-p
KBR T17-p
ketogenic diet S16-p
KN-93 T17-p
liothyronine S16-p , T17-p
low_Ca(2+) T17-p
low_pH S16-p
myocarditis T17-p
nifedipine S16-p , T17-p
norepinephrine S16-p , T17-p
obesity S16-p
okadaic_acid S16-p , T17-p
PKI S16-p
prazosin S16-p , T17-p
prednisolone T17-p
pressure S16-p , T17-p
propranolol S16-p
PUGNAc S16-gl
resistance training S16-p
serum S16-p
SMLT S16-p
streptozotocin S16-gl
W-7 T17-p
zacopride T17-p